Jähnig, L., & Visnjic, I. (2017). Responding to potentially disruptive technologies: Why do incumbent pharmaceutical companies acquire biotechnological companies and how have these motives changed over time.
Cita Chicago Style (17a ed.)Jähnig, Lukas, y Ivanka Visnjic. Responding to Potentially Disruptive Technologies: Why Do Incumbent Pharmaceutical Companies Acquire Biotechnological Companies and How Have These Motives Changed over Time. 2017.
Cita MLA (9a ed.)Jähnig, Lukas, y Ivanka Visnjic. Responding to Potentially Disruptive Technologies: Why Do Incumbent Pharmaceutical Companies Acquire Biotechnological Companies and How Have These Motives Changed over Time. 2017.
Precaución: Estas citas no son 100% exactas.